Researchers at the Broad Institute of MIT and Harvard have developed a gene-editing treatment for prion disease that extends lifespan by about 50 percent in a mouse model of the fatal ...

Colossal, values the Dallas-based startup at a staggering $10.2 billion. Besides making it the first startup founded in Texas ...

Researchers at the Broad Institute of MIT and Harvard have developed a gene-editing treatment for prion disease that extends ...

Editas Medicine (EDIT – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Yanan Zhu ...

The company said Jan. 15 that it has raised $200 million in series C funding led by TWG Global, the investment firm headed by ...

EMERYVILLE, Calif., Jan. 15, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: MGX), a precision genetic medicines company committed to ...

Colossal Biosciences, the world’s first company dedicated to bringing back animals from extinction, has secured $200 million ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

An emerging field of genetics promises to let parents choose the “healthiest” baby.

Colossal Biosciences, the company that's famously on a mission to bring back the woolly mammoth and two other extinct species ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/2.Cho0xxI9.js ...

Touchlight, an innovation-driven Contract Development and Manufacturing Organisation (CDMO), today announced that its facility in Hampton UK has received GMP certification. As a result, Touchlight ...